Vosevi as a Treatment for HCV Infection
Vosevi is a prescription medication used to treat chronic hepatitis C virus (HCV) infection. It combines three active (main) ingredients; sofosbuvir, velpatasvir, and voxilaprevir. This medication stops the virus from multiplying. Vosevi is an effective drug for the treatment of HCV
What Patients Should Know About Renflexis (Infliximab-abda)
Renflexis is supplied as a single-dose vial with the appearance of a white powder form. Each vial contains 100 mg of infliximab-abda. This medication will be administered intravenously (IV) as directed by your physician. Your doctor will calculate the required dose
What Is Inflectra (Infliximab-dyyb)?
Inflectra is an FDA-approved prescription drug used to treat several autoimmune disorders. People with autoimmune diseases have dysregulated immune systems that cause the immune cells to attack healthy tissues in the body. Inflectra is a biological product in a category of
Zirabev: What Is It and How Does It Work?
Zirabev is an anticancer drug with an active component, "bevacizumab-bvzr." It is used to treat several types of cancer and belongs to the class of vascular endothelial growth factor (VEGF) inhibitors that targets VEGF proteins and blocks their activity. In
Lanreotide (Somatuline Depot): What You Need To Know
Somatuline Depot (lanreotide) is the brand name of a prescription medication that is used to treat the following conditions -- Carcinoid syndrome: Carcinoid syndrome is a group of signs and symptoms that arise from carcinoid tumors, which are a type
Immunoglobulin G (IgG) Deficiency
Immunoglobulins are proteins made in the body that serve as antibodies. These proteins are a crucial part of the immune system as they identify and incapacitate any foreign substance in the body, such as bacteria and viruses. They form part
Kanjinti (Trastuzumab-anns) Drug Information
Kanjinti was first approved by the FDA in 2019 as a biosimilar of an already-marketed anticancer drug called Herceptin. It is classified under the pharmacologic category of antineoplastic, monoclonal antibodies, and anti-HER2 drug agents. The active substance of Kajinti is
Skyrizi (Risankizumab): What You Need to Know
Skyrizi (risankizumab) is a biologic medication used to treat different health conditions, including plaque psoriasis (severe to moderate), psoriatic arthritis, and Crohn's disease. Plaque psoriasis is a skin condition where the skin cells grow faster than they normally should.